Context Therapeutics (CNTX) Interest Expenses (2020 - 2021)

Context Therapeutics' (CNTX) quarterly Interest Expenses came in at -$315.0 in Q4 2021, down 100.33% year-on-year from $94434.0 in Q4 2020, and down 124.98% quarter-over-quarter from $1261.0 in Q3 2021.

Context Therapeutics (CNTX) Interest Expenses (2020 - 2021) Analysis & Trends

Context Therapeutics has disclosed Interest Expenses across 2 years of filings, most recently posting -$315.0 for Q4 2021.

  • Interest Expenses for Q4 2021 came in at -$315.0, down 100.33% year-over-year; the trailing twelve-month figure through Sep 2022 was -$315.0 (down 100.08% YoY), and the FY2021 annual result was $64240.0, down 90.28% from the prior year.
  • Interest Expenses came in at -$315.0 for Q4 2021 at Context Therapeutics, down from $1261.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $300000.0 in Q1 2021 to a low of -$315.0 in Q4 2021.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -5.50 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 61,000.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -332,000.00
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -2,753.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -5.58 Mn
10 Context Therapeutics 166.57 Mn 166.57 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 -315.00
Dec 31, 2021 -315.00
Sep 30, 2021 1,261.00
Sep 30, 2021 1,261.00
Mar 31, 2021 300,000.00
Mar 31, 2021 300,000.00
Dec 31, 2020 94,434.00
Dec 31, 2020 94,434.00
Sep 30, 2020 95,211.00
Sep 30, 2020 95,211.00